MIR4765

Across TCGA pan-cancer cohorts, MIR4765 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR4765 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher MIR4765 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4765 expression acts as an unfavorable survival marker, although some lineages such as SARC show a favorable association.

LIHC, ESCA, and UCEC are the cancer types where MIR4765 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.051	0.783	<.001	108	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
UCEC	OS	Tertile	All	0.881	0.928	.004	36	view →
COAD	DFS	Tertile	IV	0.028	0.496	<.001	18	view →
HNSC	OS	Tertile	III,IV	0.368	0.662	.035	18	view →
CESC	DFS	Tertile	IV	0.053	0.529	<.001	18	view →
KIRC	DFS	Tertile	All	0.174	0.627	.020	12	view →
READ	OS	Tertile	All	0.253	0.688	.019	12	view →
LUSC	DFS	Tertile	II,III,IV	0.135	0.663	.015	9	view →
SARC	DFS	Tertile	All	1.000	0.331	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR4765–LIHC (OS)

Open the LIHC breakdown →